News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,016 Results
Type
Article (1682)
Company Profile (12)
Press Release (68322)
Section
Business (30932)
Career Advice (49)
Deals (5469)
Drug Delivery (4)
Drug Development (8234)
Employer Resources (6)
FDA (1413)
Job Trends (1863)
News (43790)
Policy (2489)
Tag
Academia (127)
Accelerated approval (1)
Allergies (16)
Alliances (2364)
ALS (4)
Alzheimer's disease (137)
Antibody-drug conjugate (ADC) (9)
Approvals (1434)
Artificial intelligence (22)
Autoimmune disease (1)
Automation (1)
Bankruptcy (16)
Best Places to Work (1824)
BIOSECURE Act (1)
Biosimilars (4)
Biotechnology (11)
Bladder cancer (23)
Brain cancer (2)
Breast cancer (39)
Cancer (313)
Cardiovascular disease (24)
Career advice (49)
Career pathing (5)
CAR-T (4)
Cell therapy (27)
Cervical cancer (3)
Clinical research (7265)
Collaboration (42)
Compensation (542)
Complete response letters (1)
COVID-19 (238)
CRISPR (3)
C-suite (20)
Cystic fibrosis (14)
Data (374)
Depression (6)
Diabetes (32)
Diagnostics (770)
Digital health (3)
Diversity, equity & inclusion (2)
Drug discovery (8)
Drug pricing (5)
Duchenne muscular dystrophy (5)
Earnings (26445)
Editorial (3)
Employer branding (2)
Employer resources (5)
Events (6851)
Executive appointments (57)
FDA (1610)
Frontotemporal dementia (2)
Funding (36)
Gene editing (6)
Generative AI (2)
Gene therapy (25)
GLP-1 (62)
Government (295)
Guidances (96)
Healthcare (2831)
Huntington's disease (1)
Immunology and inflammation (12)
Indications (5)
Infectious disease (247)
Inflammatory bowel disease (26)
Inflation Reduction Act (1)
Influenza (5)
Intellectual property (5)
Interviews (4)
IPO (4441)
IRA (3)
Job creations (146)
Job search strategy (41)
Kidney cancer (4)
Labor market (7)
Layoffs (25)
Legal (357)
Liver cancer (5)
Lung cancer (62)
Lymphoma (27)
Machine learning (1)
Management (1)
Manufacturing (14)
MASH (13)
Medical device (1804)
Medtech (1804)
Mergers & acquisitions (1119)
Metabolic disorders (80)
Multiple sclerosis (14)
NASH (2)
Neurodegenerative disease (7)
Neuropsychiatric disorders (2)
Neuroscience (189)
NextGen: Class of 2025 (704)
Non-profit (176)
Obesity (36)
Opinion (3)
Ovarian cancer (8)
Pain (10)
Pancreatic cancer (9)
Parkinson's disease (10)
Partnered (1)
Patents (8)
Patient recruitment (11)
Peanut (9)
People (2938)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1726)
Phase II (2814)
Phase III (3222)
Pipeline (511)
Policy (4)
Postmarket research (284)
Preclinical (509)
Press Release (2)
Prostate cancer (8)
Psychedelics (1)
Radiopharmaceuticals (18)
Rare diseases (30)
Real estate (251)
Recruiting (3)
Regulatory (2022)
Reports (10)
Research institute (113)
Resumes & cover letters (4)
RSV (6)
Schizophrenia (12)
Series A (1)
Series B (1)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (19)
Sponsored (1)
Startups (101)
Stomach cancer (1)
Supply chain (2)
Tariffs (2)
Vaccines (46)
Venture capitalists (2)
Weight loss (19)
Women's health (1)
Worklife (2)
Date
Today (38)
Last 7 days (252)
Last 30 days (537)
Last 365 days (5117)
2025 (1916)
2024 (5537)
2023 (6105)
2022 (7110)
2021 (7505)
2020 (6810)
2019 (5010)
2018 (3741)
2017 (3237)
2016 (2213)
2015 (3027)
2014 (2543)
2013 (1388)
2012 (1559)
2011 (1691)
2010 (1588)
Location
Africa (45)
Alabama (5)
Arizona (13)
Asia (3739)
Australia (455)
California (1098)
Canada (258)
China (58)
Colorado (45)
Connecticut (48)
Delaware (45)
Europe (9790)
Florida (178)
Georgia (17)
Idaho (3)
Illinois (44)
India (1)
Indiana (51)
Japan (24)
Kansas (5)
Kentucky (3)
Louisiana (4)
Maine (12)
Maryland (105)
Massachusetts (805)
Michigan (28)
Minnesota (42)
Missouri (8)
Montana (4)
Nevada (10)
New Hampshire (9)
New Jersey (323)
New York (260)
North Carolina (144)
Northern California (552)
Ohio (29)
Oklahoma (1)
Oregon (2)
Pennsylvania (213)
South America (88)
South Carolina (1)
Southern California (432)
Tennessee (11)
Texas (139)
United States (3768)
Utah (40)
Virginia (9)
Washington D.C. (16)
Washington State (92)
West Virginia (1)
Wisconsin (3)
70,016 Results for "56".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LIB Therapeutics Announces Key Results from Presentations at 2025 European Atherosclerosis Society Meeting in Glasgow May 5-6
May 7, 2025
·
5 min read
Press Releases
Immunoassay Market Size Expected to Hit USD 56.20 Billion by 2034
February 20, 2025
·
1 min read
Press Releases
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
March 7, 2025
·
4 min read
Press Releases
U.S. Radiation Oncology Market Size to Hit USD 14.56 Billion by 2033
February 26, 2025
·
1 min read
Press Releases
Small Molecule API Market Size to Reach USD 331.56 Bn by 2034
February 5, 2025
·
1 min read
Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024
Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced its participation in the Jefferies Healthcare Conference in New York on June 5-6, 2024.
May 29, 2024
·
2 min read
Press Releases
Digital Therapeutics Market Size Expected to Hit USD 56.76 Bn by 2034
December 13, 2024
·
1 min read
Biotech Bay
Attralus Closes $56 Million Financing
Attralus, Inc., a clinical-stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, announced that it has closed a $56 million financing.
February 6, 2024
·
7 min read
Press Releases
Neuroimaging Market Size to Reach USD 56.58 Billion By 2030
November 14, 2024
·
1 min read
Business
Eisai projects Leqembi® revenue to total JPY 56.5 billion for fiscal year 2024 (April 2024 - March 2025)
BioArctic AB’s partner Eisai said that they expect Leqembi sales to total JPY 56.5 billion for their fiscal year 2024.
May 15, 2024
·
5 min read
1 of 7,002
Next
